MOUNTAIN VIEW – USA: A groundbreaking shift in cancer treatment is dawning in Nevada, as Mountain View Hospital unveils the first facility in the state to provide both CAR T-cell therapy and allogenic stem cell transplants. This state-of-the-art, 12,000 square-foot day hospital opened its doors on June 25th, presenting a game-changing opportunity for local patients battling aggressive forms of cancer such as leukemia and lymphoma. Previously, many families endured significant financial strain and stress by traveling out of state to access such specialized treatments.
Dr. Caroline Mulroney, the Medical Director of the Sarah Cannon Transplant and CAR T-cell Therapy Program, emphasizes the importance of these procedures in fighting and potentially curing various blood cancers. By harnessing the power of patients’ own immune systems, these therapies offer hope where traditional treatments have failed. The hospital’s innovative approach allows patients to stay close to their families while receiving cutting-edge care, transforming the treatment landscape in the region.
Maria Rios, the Administrative Director at Mountain View Hospital, reflects on the significance of this new outpatient facility. It not only signifies a step forward for healthcare in Nevada, but also ensures that patients can leave the hospital each day, allowing them to rest in the comfort of their own homes and be surrounded by loved ones. With the dedicated infrastructure and expertise in cell therapy manufacturing, the hospital stands poised to change the lives of countless individuals and families facing the overwhelming challenge of cancer.
This remarkable advancement is already making waves within the medical community, heralding a new era of hope and healing for those who need it most. Excitement brews as the facility commences its mission to deliver innovative care right where patients need it—close to home.
